AzTrials
AzTrials

Knee OsteoarthritisNCT04951414

Study on the Rehabilitation Treatment of Knee Osteoarthritis Based on ICF

An observational study of Knee Osteoarthritis, run by Peking University Third Hospital at 2 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To solve the existing Knee osteoarthritis;KOA) clinical norms and guidelines have low operability, Disconnection between treatment plan and specific evaluation results, difficulty in achieving individualized intervention and other problems, on the one hand, we need to develop Chinese expert consensus or clinical path… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Knee Osteoarthritis
What is being tested?
ICF core set
How many people
600 participants
Where
2 sitesChina
Study dates
1 Jul 2021to 31 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Six hundred patients with knee osteoarthritis were treated in each participating research unit

Who may be able to join

  • Neither knee had undergone knee replacement, and no knee replacement had been performed in recent half a year planning to have a knee replacement; Volunteered to participate in the study and signed the informed consent.

Who cannot join

  • People with consciousness disorder, cognitive disorder, severe mental illness, unable to accurately express their own will, or unable to cooperate with the completion of various assessments and treatment

Trial locations and contacts

2 sites in 1 country.

YUANMINGFEI ZHANG contact

+8615201469083

zymf@pku.edu.cn

China2 sites, 2 recruiting
  • Capital clinical characteristic applied research and achievement promotion

    Beijing, Beijing Municipality, 100191

    Mouwang Zhou, +86 15611908378, zhoumouwang@163.com

    Recruiting
  • Huarunwugang general hospital

    Wuhan, Hubei

    Yuanmingfei Zhang, Dr., +86 15201469083, zymf@pku.edu.cn

    Recruiting

Other trials in China

About this study

To solve the existing Knee osteoarthritis;KOA) clinical norms and guidelines have low operability, Disconnection between treatment plan and specific evaluation results, difficulty in achieving individualized intervention and other problems, on the one hand, we need to develop Chinese expert consensus or clinical path based on evidence-based medicine to adapt to China's national conditions, on the other hand, is more important in The KOA clinical process introduces a set of tools to translate evidence-based medicine evidence into specific, actionable treatments, Thus, a more flexible, more comprehensive and three-dimensional, adaptable, targeted, more conducive to the promotion of the individual integration KOA rehabilitation intervention program.

Being tested
ICF core set
Medical subject headings
Osteoarthritis, Knee

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ICF core setDiagnostic test

    KOA rehabilitation regimen based on the complete core combination of ICF was accepted

Study groups in NCT04951414
Study groupRoleWhat they receive
ICFNot described
Receives: Diagnostic Test: ICF core set
ControlNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. treatment compliance

    treatment compliance of rehabilitation treatment

    Measured: 1month

  2. treatment compliance

    treatment compliance of rehabilitation treatment

    Measured: 3month

  3. treatment compliance

    treatment compliance of rehabilitation treatment

    Measured: 6month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2021
  2. Study start1 Jul 2021 (estimated)
  3. Primary completion31 Dec 2022 (estimated)
  4. Study completion31 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04951414
Sponsor's protocol ID
D181100000318004
Status last verified
Jun 2021
First submitted
27 Jun 2021
Last updated
6 Jul 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Knee Osteoarthritis, run by Peking University Third Hospital at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tao Li, Dr (+8613811397872, tobetheone@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

treatment compliance (time frame: 1month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in